pfizer glp 1 news GLP-1 weight loss drug available for pre-order in China pfizer glp 1 Pfizer enters

Developed by Innovent Biologics, it rivals Western treatments like Ozempic while enhancing affordability amid Chinas soaring diabetes burden

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist

Some Kaiser plans cover Zepbound, but coverage varies by plan and may depend on the reason youre taking it

Innovations in drug delivery methods and sustained R&D investments further enhance market potential

Rich &amp